PCI in severely degenerated saphenous vein graft using a novel mesh-covered stent together with a conventional embolic protection system.
نویسندگان
چکیده
Although the protection with filter-based devices during percutaneous coronary intervention (PCI) in a saphenous vein graft (SVG) reduces major adverse cardiac events, a large number of patients undergoing SVG PCI still experience these events. New methods must be used in order to reduce this incidence. Novel local plaque-trapping stents have been developed and show promise in pilot human testing. We present 2 cases of patients with degenerated SVGs and a large amount of plaque volume, who underwent coronary angioplasty in our department. Considering the high risk of distal embolization, we used a standard distal embolic protection system and a recently developed mesh-covered stent. This combination approach has not yet been studied very well.
منابع مشابه
Secondary prevention, the interventional way: prophylactic drug-eluting stents for nonobstructive saphenous vein graft disease.
The pathophysiology of accelerated atherosclerosis in saphenous vein grafts (SVG) relates to progressive atheroma burden, neointimal hyperplasia, and vascular remodeling.1,2 Unfortunately, the therapeutic and clinical consequences of SVG disease are not trivial, and interventional cardiologists are wary of performing percutaneous coronary interventions (PCI) on degenerated SVG. Intervening on f...
متن کاملEffect of percutaneous coronary interventions for in-stent restenosis in degenerated saphenous vein grafts without distal embolic protection.
OBJECTIVES This study was designed to investigate the impact of percutaneous coronary interventions (PCIs) in degenerated saphenous vein grafts (SVGs) without distal embolic protection. BACKGROUND Distal embolic protection devices have been shown to reduce the incidence of no reflow/slow flow during PCI of de novo lesions in degenerated SVGs. It is unclear whether PCI of in-stent restenosis (...
متن کاملComeback for glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions for saphenous vein bypass grafts: may be for distal protection with filter-based devices?
Long-term outcome of coronary bypass surgery (CABG) is limited by progressive and significant narrowing of vein grafts in about half the patients within 10 to 15 years after operation. Despite a reduced world-wide trend for bypass operations and more widespread utilization of arterial conduits during CABG, treatment of symptomatic patients with degenerated aorto-coronary bypass vein grafts will...
متن کاملA novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions: results of the AMEthyst randomized controlled trial.
OBJECTIVES We sought to evaluate the relative safety and efficacy of the novel Interceptor PLUS Coronary Filter System (Medtronic Vascular, Santa Rosa, California) compared with approved embolic-protection devices (e.g., GuardWire, Medtronic Vascular/FilterWire EZ, Boston Scientific, Natick, Massachusetts) during percutaneous coronary intervention (PCI) of degenerative saphenous vein grafts (SV...
متن کاملEmbolic protection during saphenous vein graft intervention using a second-generation balloon protection device: results from the combined US and European pilot study of the TriActiv Balloon Protected Flush Extraction System.
BACKGROUND Stent placement in saphenous vein bypass grafts is associated with a high incidence of myonecrosis usually resulting from embolization of thrombus and friable atheroma. Embolic protection devices reduce the incidence of adverse events after vein graft stenting. However, first-generation balloon occlusion systems are still associated with a 10% incidence of periprocedural adverse even...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese
دوره 50 5 شماره
صفحات -
تاریخ انتشار 2009